The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Expert Testimony - Novartis
Epigenetic regulation of the Wnt-signaling pathway in CIMP-H BRAFV600E mCRC.
 
Hey Min Lee
Stock and Other Ownership Interests - Medtronic
 
Stefania Napolitano
No Relationships to Disclose
 
Van K. Morris
Honoraria - Projects in Knowledge
Consulting or Advisory Role - Array Biopharma; Incyte; SERVIER
Research Funding - Array BioPharma (Inst); Boehringer Ingelheim; Bristol-Myers Squibb (Inst); EMD Serono (Inst)
 
Kunal Rai
No Relationships to Disclose
 
John Paul Y.C. Shen
Stock and Other Ownership Interests - Agios; Syndax; Syndax
 
Jennifer S. Davis
No Relationships to Disclose
 
Dipen M. Maru
No Relationships to Disclose
 
Michael J. Overman
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Gritstone Bio; Janssen; Janssen; MedImmune; Novartis; Pfizer; Pfizer; Promega; Roche/Genentech; Spectrum Pharmaceuticals
Research Funding - Bristol-Myers Squibb; MedImmune; Merck; Roche
 
Ji Wu
No Relationships to Disclose
 
Oluwadara Coker
No Relationships to Disclose
 
Melanie Nicole Woods
No Relationships to Disclose
 
Oscar Villarreal
No Relationships to Disclose
 
Scott Kopetz
Stock and Other Ownership Interests - Lutris; MolecularMatch; Navire
Consulting or Advisory Role - Amal Therapeutics; Amgen; AstraZeneca/MedImmune; Bayer Health; Biocartis; Boehringer Ingelheim; Boston Biomedical; Daiichi Sankyo; EMD Serono; EMD Serono; Genentech; HalioDx; Holy Stone Healthcare; Ipsen; Jacobio; Karyopharm Therapeutics; Lilly; Lutris; Merck; Natera; Navire; Novartis; Pfizer; Pierre Fabre; Redx Pharma; Repare Therapeutics; Roche; Symphogen
Research Funding - Amgen (Inst); Array BioPharma (Inst); Biocartis (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Guardant Health (Inst); Lilly (Inst); MedImmune (Inst); Novartis (Inst); Sanofi (Inst)